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Abdominal aortic aneurysm (AAA) is characterized by a gradual dilation of abdominal aorta, which is typically asymptomatic until rupture. There is currently no drug for preventing AAA development. Several studies have recently reported the effect of n-3 polyunsaturated fatty acid (PUFA), particularly eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on AAA development, which is formed in AAA animal models. EPA treatment reportedly attenuates CaCl~2~-induced AAA formation, elastic lamina destruction, and aortic calcification^[@bib1])^. Yoshihara *et al.* reported that EPA and DHA suppress AAA development induced by angiotensin II infusion in apolipoprotein E-deficient mice^[@bib2])^. Using the same experimental mouse model, Russell *et al.* reported that dietary supplementations of n-3 PUFA attenuate matrix metalloproteinase 9 immunoreactivity^[@bib3])^. They also reported a trend of a delay in AAA-related death in mice that were fed n-3 PUFA diet^[@bib4])^. Using a newly developed AAA animal model^[@bib5])^, Kugo *et al.* reported that EPA-rich fish oil prevented AAA development^[@bib6])^ induced by hypoperfusion of the vascular wall. These studies suggested that n-3 PUFA has preventive effects on AAA development in different AAA animal models. The mechanism of action of n-3 PUFA is generally considered to be associated with antiinflammatory and antioxidant activities^[@bib7])^. Recent studies show that abnormal appearance of adipocyte in vascular wall may induce AAA rupture^[@bib8],\ [@bib9])^. The risk for AAA rupture decreased following fish oil administration, with the decreased number and size of ectopic adipocytes in the vascular wall^[@bib8])^. The hypolipidemic effect of n-3 PUFA might be involved in the preventive effect on AAA development or rupture.

In contrast to the increasing evidences from animal studies, the effect of n-3 PUFA on human AAA remains unknown. In the current issue of *Journal of Atherosclerosis and Thrombosis*, Aikawa *et al.* analyzed 67 patients who were admitted for elective surgical repair of AAA. They estimated the correlation of serum EPA, DHA, and EPA/arachidonic acid (AA) ratio with the size and growth rate of AAA^[@bib10])^. Their study indicated that low serum EPA levels (low EPA/AA ratio) were significantly associated with the size and growth rate of AAA diameter (*r* = −0.43 and *r* = −0.33, respectively). Interestingly, serum DHA levels did not correlate with AAA formation in their study group. It is of interest to clarify the difference between the effects of each n-3 PUFA on AAA development.

Their cross-sectional study did not show the causal association between n-3 PUFA and AAA development. However, this first study in a clinical setting provided an important finding to estimate the effect of n-3 PUFA on human AAA development. Further investigation should be performed to clarify the association between n-3 PUFA and human AAA development.
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